Exploration of comprehensive marine natural products database against dengue viral non-structural protein 1 using high-throughput computational studies.

ADMET analysis NS1 protein dengue virus high-throughput virtual screening marine compounds molecular docking

Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
02 Jan 2024
Historique:
medline: 2 1 2024
pubmed: 2 1 2024
entrez: 2 1 2024
Statut: aheadofprint

Résumé

Dengue virus (DENV) non-structural protein 1 (NS1) is a versatile quasi-protein essential for the multiplication of the virus. This study applied high-throughput virtual screening (HTVS) and molecular dynamics (MD) simulation to detect the potential marine natural compounds against the NS1 of DENV. The structure of the NS1 protein was retrieved from Protein Data Bank with (PDB ID: 4O6B). Missing residues were added using modeler software. Molecular operating environment (MOE) programme was used to prepare the protein before docking. Virtual screening was performed on PyRx software to identify natural compounds retrieved from Comprehensive Marine Natural Products Database (CMNPD) against the NS1 protein, and best-docked compounds were examined by molecular docking and molecular dynamic (MD) simulation. Out of 31,561 marine compounds, the top 10 compounds showed docking scores lesser than -8.0 kcal/mol. One of the best hit compounds, CMNPD6802, was further analyzed using MD simulation study at 100 nanoseconds and Molecular Mechanics with Generalized Born and Surface Area Solvation (MM/GBSA). Based on its total binding energy, determined using the MM/GBSA approach, CMNPD6802 was ranked first. Its pharmacokinetic properties concerning the target protein NS1 were also evaluated. The results of the MD simulation showed that CMNPD6802 remained in close contact with the protein throughout the activation period, mapped using principal component analysis. These findings suggest that CMNPD6802 could serve as an NS1 inhibitor and may be a potential candidate for treating DENV infections.Communicated by Ramaswamy H. Sarma.

Identifiants

pubmed: 38165485
doi: 10.1080/07391102.2023.2297006
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Basharat Ahmad Bhat (BA)

Department of BioResources, Amar Singh College Campus, Cluster University Srinagar, India.

Abdullah Algaissi (A)

Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Emerging and Epidemic Infectious Diseases Research Unit, Medical Research Centre, Jazan University, Jazan, Saudi Arabia.

Nizar A Khamjan (NA)

Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.

Tanvir Ul Hassan Dar (TUH)

Department of Biotechnology, School of Biosciences and Biotechnology, BGSB University, Rajouri, India.

Sajad Ahmad Dar (SA)

Research and Scientific Studies Unit, College of Nursing, Jazan University, Jazan, Saudi Arabia.

Venkatramanan Varadharajan (V)

Department of Biotechnology, PSG College of Technology, Coimbatore, India.

Naif A Qasir (NA)

Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Medical Research Centre, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.

Mohtashim Lohani (M)

Medical Research Centre, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.

Classifications MeSH